phosphotyrosine has been researched along with valproic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berezin, V; Bock, E; Kawa, A; Skladchikova, G; Walmod, PS | 1 |
| Bosi, A; Buchi, F; Ferrari, G; Gozzini, A; Pastorelli, R; Santini, V; Sassolini, F; Spinelli, E; Tombaccini, D | 1 |
2 other study(ies) available for phosphotyrosine and valproic acid
| Article | Year |
|---|---|
Antiepileptic teratogen valproic acid (VPA) modulates organisation and dynamics of the actin cytoskeleton.
Topics: Actins; Actomyosin; Adenosine Triphosphate; Animals; Anticonvulsants; Cell Adhesion; Cell Adhesion Molecules; Cell Movement; Cell Size; Cells, Cultured; Cytochalasin D; Cytoskeletal Proteins; Cytoskeleton; Dose-Response Relationship, Drug; Fibroblasts; Focal Adhesion Protein-Tyrosine Kinases; Gelsolin; Microscopy, Confocal; Microscopy, Fluorescence; Nocodazole; Octoxynol; Paxillin; Peptides; Phosphoproteins; Phosphotyrosine; Protein-Tyrosine Kinases; Teratogens; Time Factors; Trypsin; Tubulin; Valproic Acid; Vinculin | 1999 |
Acetylome and phosphoproteome modifications in imatinib resistant chronic myeloid leukaemia cells treated with valproic acid.
Topics: Acetylation; Apoptosis; Benzamides; Blotting, Western; Cell Proliferation; Drug Resistance, Neoplasm; Electrophoresis, Gel, Two-Dimensional; Fusion Proteins, bcr-abl; Histone Deacetylase Inhibitors; Humans; Imatinib Mesylate; Immunoprecipitation; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Phosphotyrosine; Piperazines; Protein Kinase Inhibitors; Proteome; Pyrimidines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tumor Cells, Cultured; Valproic Acid | 2011 |